Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)

J Infect Dis. 2018 May 18;217(suppl_1):S1-S5. doi: 10.1093/infdis/jix665.

Authors

Anne Schuchat¹, Jane F Seward¹, Susan T Goldstein¹, Barbara E Mahon¹

Affiliation

¹ Centers for Disease Control and Prevention, Atlanta, Georgia.

No abstract available

Publication types

Introductory Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Drug-Related Side Effects and Adverse Reactions / epidemiology
Drug-Related Side Effects and Adverse Reactions / pathology
Ebola Vaccines / administration & dosage*
Ebola Vaccines / adverse effects*
Epidemics*
Hemorrhagic Fever, Ebola / epidemiology*
Hemorrhagic Fever, Ebola / prevention & control*
Humans
Randomized Controlled Trials as Topic
Sierra Leone / epidemiology

Substances

Ebola Vaccines